对辅助剂进行系统选,以稳定气溶液中的脂质纳米颗粒,以增强mRNA输送
Brittany J Heiser1, Mae M Lewis1, Meysam Mohammadi Zerankeshi2
1Department of Biomedical Engineering, The University of Texas at Austin Austin Texas USA.
RSC pharmaceutics
|July 21, 2025
概括
在吸入治疗期间,Poloxamer 188稳定了气溶液中的信使RNA (mRNA) 脂质纳米粒子 (LNP). 这种配方策略保持了LNP大小,并增强了用于治疗肺部疾病的mRNA输送.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 肺部药物输送 肺部药物输送
背景情况:
- 携带信使RNA (mRNA) 的气溶液脂质纳米粒子 (LNPs) 提供了局部肺部疾病治疗的潜力.
- 在气溶化过程中,切削力会破坏mRNA LNP的稳定,降低它们的有效性.
- 保持mRNA LNP的物理化学性质对于有效的吸入疗法至关重要.
研究的目的:
- 为了确定在气溶化过程中稳定mRNA LNP的辅助剂.
- 为了提高吸入mRNA LNP输送用于肺部疾病的疗效.
主要方法:
- 一个基于配方的策略,使用实验设计 (DOE) 方法来选辅助剂.
- 辅助剂修饰的mRNA LNP的表征.
- 人类肺细胞在空气-液体界面的体外转移.
主要成果:
- 波洛克萨默188被确定为稳定mRNA LNP的主要候选者.
- 波洛克萨默188在气溶液中保持了LNP大小,并在气溶液后增强了mRNA表达.
- 形态学研究表明,波洛克萨默188可以减少颗粒的融合/聚合,而不会改变内部结构.
结论:
- 波洛克萨默188显著提高了气溶mRNA LNP的稳定性和有效性.
- 这种辅助剂支持用于肺部疾病的可吸入mRNA治疗药物的开发.
- 波洛克萨默188增强了通过气溶向肺细胞输送核酸的作用.
更多相关视频
08:55Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
Published on: January 20, 2023
12.0K
08:54Determining Four Components in a Lipid Nanoparticle RNA Delivery System by Liquid Chromatography Combined with Evaporative Light Scattering Detector
Published on: May 30, 2025
843
相关概念视频
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...